PANORAMA - A phase 3, double-masked, randomized study of the efficacy and safety of intravitreal aflivercept injections in patients with moderately sever to severe nonproliferative diabetic retinopathy
Laufzeit: 01.01.2017 - 31.12.2017
Kurzfassung
A phase 3, double-masked, randomized study of the efficacy and safety of intravitreal aflivercept injections in patients with moderately sever to severe nonproliferative diabetic retinopathy
